Advances in research of dihydroartemisinin against parasitic diseases

Chinese Journal of Schistosomiasis Control

Volumn 23, Issue 4, 2011, Pages 460-464

  Li, Hong Jun ^a   Wang, Wei ^a   Hang, You Sheng ^a  

^a JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

Author keywords

Anti parasitic activity; Dihydroartemisinin; Protozoan; Schistosome

Indexed keywords

DIHYDROARTEMISININ; ARTEMISININ DERIVATIVE;

DRUG RESEARCH; GIARDIA LAMBLIA; LEISHMANIA; NONHUMAN; PARASITOSIS; PLASMODIUM; PNEUMOCYSTIS; REVIEW; SCHISTOSOMA; SYSTEMATIC REVIEW; TOXOPLASMA; TRICHOMONAS VAGINALIS; ANIMAL; DRUG EFFECT; HUMAN; PARASITE; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; ARTEMISININS; HUMANS; PARASITES; PARASITIC DISEASES;

EID: 84855441117     PISSN: 10056661     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Effects of dihydroartemisinin on fine structure of erythrocytic stages of Plasmodium berghei ANKA strain[J]. 2000,21(3):234-238.
2. Diem Thuy le T, Na-Bangchang K, Hung le N, et al. Clinical efficacy of high dose monotherapy of oral dihydroartemisinin in uncomplicated falciparum malaria in Viet nam [J]. Jpn J Infect Dis, 2007, 60(4): 161-166.
3. Brice BK, William Y, Lacina O, et al. In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine[J]. Tanzan J Health Res, 2010, 12(1): 73-79.
4. Nsobya SL, Kiqqundu M, Nanyunja S, et al. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda [J]. Antimicrob Agents Chemother, 2010, 54(3): 1200-1206.
5. Mwai L, Kiara SM, Abdirahman A, et al. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1 [J]. Antimicrob Agents Chemother, 2009, 53(12): 5069-5073.
6. Tahar R, Ringwald P, Basco LK. Molecular epidemiology of malaria in Cameroon. XXVIII In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum and sequence analysis of the P. falciparum ATPase 6 gene[J]. Am J Trop Med Hyg, 2009, 81(1): 13-18.
7. Mayxay M, Barends M, Brockman A, et al. In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos) [J]. Am J Trop Med Hyg, 2007, 76(2): 245-250. (Pubitemid 351627769)
8. Tinto H, Rwagacondo C, Karema C, et al. In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda[J]. Trans R Soc Trop Med Hyg, 2006, 100(6): 509-514.
9. Li HJ, Wang W, Li YZ, et al. Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum [J]. Parasitol Res, 2011, 109(2): 515-519.
10. SarCiron ME, Saccharin C, Petavy AF, et al. Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii[j]. Am J Trop Med Hyg, 2000, 62(1): 73-76.
11. Ma Y, Lu DM, Lu XJ, et al. Activity of dihydroartemisinin against Leishmania donovani both in vitro and vivo[J]. Chin Med J (Engl), 2004, 117(8): 1271-1273. (Pubitemid 39199942)
12. Galal AM, Gul W, Slade D, et al. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity[J]. Bioorg Med Chem, 2009, 17(2): 741-751.
13. Tian XF, Shen HE, Li J, et al. The effects of dihydroartemisinin on Giardia lamblia morphology and cell cycle in vitro[J]. Parasitol Res, 2010, 107(2): 369-375.
14. Berriman M, Haas BJ, LoVerde PT, et al. The genome of the blood fluke Schistosoma mansoni[J]. Nature, 2009, 460(7253): 352-358.
15. Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium. The Schistosoma japonicum genome reveals features of host-parasite interplay[J]. Nature, 2009, 460(7253): 345-351.